We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
20 hedge funds and large institutions have $3.75M invested in Interpace Biosciences, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
11% more funds holding
Funds holding: 18 → 20 (+2)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
47% less capital invested
Capital invested by funds: $7.02M → $3.75M (-$3.27M)
Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$240K |
| 2 |
JP Morgan Chase
New York
|
-$194K |
| 3 |
Millennium Management
New York
|
-$57K |
| 4 |
Jane Street
New York
|
-$36K |
| 5 |
WP
WealthSource Partners
San Luis Obispo,
California
|
-$17.3K |
